請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35634完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 吳漢忠(Han-Chung Wu) | |
| dc.contributor.author | Mei-Ying Liao | en |
| dc.contributor.author | 廖美英 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:02:13Z | - |
| dc.date.available | 2007-08-04 | |
| dc.date.copyright | 2005-08-04 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-27 | |
| dc.identifier.citation | Aaskov, J. G., Geysen, H. M., and Mason, T. J. (1989) Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409). Arch. Virol. 105:209-221.
Adams, S. C., Broom, A. K., Sammels, L. M., Hartnett, A. C., Howard, M. J., Coelen, R. J., Mcdkenzie, J. S. and Hall, R. A. (1995) Glycosylation and antigenic variation among Kunjin virus isolates. Virology 206:49-66. Akeson, A. L., Woods, C. W., Hsieh, L. C. and 8 other authors (1996). AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J. Biol. Chem. 271:30517–30523. Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W., and Heinz, F. X. (2001) Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75(9):4268-4275. Almond, J., Clemens, J., Engers, H. et al. (2002) Accelerating the development and introduction of a dengue vaccine for poor children, 5–8 December 2001, Ho Chi Minh City, VietNam. Vaccine 20:3043–6. Anderson, R., King, A.D. and Innis, B.L.(1992) Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J. Gen. Virol. 73:2155–9. Arap, W., Haedicke, W., Bernasconi, M. and 7 other authors (2002). Targeting the prostate for destruction through a vascular address. Proc. Natl. Acad. Sci. U.S.A. 99:1527–1531. Arap, W., Pasqualini, R. and Ruoslahti, E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377–380. Arroyo, J., Miller, C., Catalan, J. et al. (2004) ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J. Virol. 78:12497–507. Atwell, S., Ultsch, M., De Vos, A. M. and Wells, J. A. (1997). Structural plasticity in a remodeled protein–protein interface. Science 278:1125–1128. Barlow, D. J., Edwards, M. S. and Thornton, J. M. (1986) Continuous and discontinuous protein antigenic determinants. Nature 322:747–748. Barry, M. A., Dower, W. J. and Johnston, S. A. (1996) Toward celltargeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2:299–305. Barry, M. A., Dower, W. J. and Johnston, S. A. (1996) Toward celltargeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2:299–305. Beasley, D.W., Li, L., Suderman, M.T. et al. (2004) Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine 22:3722–6. Bielefeldt-Ohmann, H. (1997) Pathogenesis of dengue virus diseases: missing pieces in the jigsaw. Trend.s Microbiol. 5:409–413. Bokisch, V. A., Top, F. H. J., Russell, P. K., Dixon, F. J. and Muller-Eberhard, H. J. (1973) The potential pathogenic role of complement in dengue in dengue hemorrhagic shock syndrome. New England Journal of Medicine 289:996-1000. Bottger, A., Bottger, V., Sparks, A., Liu, W. L., Howard, S. F. and Lane, D. P. (1997) Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol. 7:860–869. Bottger, V., Bottger, A., Howard, S. F., Picksley, S. M., Chene, P., Garcia-Echeverria, C., Hochkeppel, H. K. and Lane, D. P. (1996) Identification of novel mdm2 binding peptides by phage display. Oncogene 13:2141–2147. Burke, D.S., Nisalak, A., Johnson, D.E. and Scott, R.M. (1988) A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38:172–80. Castano, A. R., Tangri, S., Miller, J. E., Holcombe, H. R., Jackson, M. R., Huse, W. D., Kronenberg, M. and Peterson, P. A. (1995) Peptide binding and presentation by mouse CD1. Science 269:223–226. Chambers, T. J., McCourt, D. W. and Rice, C. M. (1990) Production of yellow fever virus proteins in infected cells: Identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. Virology 177:159-174. Chen, Y. C., Wand, S. Y. and King, C. C. (1999) Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J. Virol. 73:2650-2657. Cortese, R., Felici, F., Galfre, G., Luzzago, A., Monaci, P. and Nicosia, A. (1994) Epitope discovery using peptide libraries displayed on phage. Trends. Biotechnol. 12:262–267. DeLeo, F. R., Yu, L., Burritt, J. B., Loetterle, L. R., Bond, C. W., Jesaitis, A. J. and Quinn, M. T. (1995) Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Pro.c Natl. Acad. Sci. U. S. A. 92:7110–7114. Deubel, V., Schlesinger, J. J., Digoutte, J. P. and Girard, M. (1987) Comparative immunochemical and biological analysis of African and south American yellow fever virusis. Arch. Virol. 94(3-4):331-8. Durbin, A.P., Whitehead, .SS., McArthur, J. et al., (2005) rDEN4D30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. J. Infect. Dis. 191:710–8 (in this issue). Edelman, R., Wasserman, S.S., Bodison, S.A. et al., (2003) Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. Am. J. Tro.p Med. Hyg. 69:48–60. Essler, M. and Ruoslahti, E. (2002). Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl. Acad. Sci. U. S. A. 99:2252–2257. Folgori, A., Tafi, R., Meola, A., Felici, F., Galfre, G., Cortese, R., Monaci, P. and Nicosia, A. (1994) A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J. 13:2236–2243. Gubler, D. J. (1998) Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480–496. Gubler, D. J., Suharyono, W., Lubis, I., Dram, S. and Gunarso, S. (1981) Epidemic dengue 3 in central Java, associated with low viremia in man. Am. J. Trop. Med. Hyg. 30:1094-1099. Guirakhoo, F., Pugachev, K., Arroyo, J. et al. (2002) Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology 298:146–59. Guzman, M.G., Kouri, G.P., Bravo, J., Soler, M., Vazquez, S. and Morier, L. (1990) Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42:179–184. Halstead, S.B., Lan, N.T., Myint, T.T. et al. (2002) Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg. Infect. Dis. 8:1474–9. Halstead, S.B., Nimmannitya, S. and Cohen, S.N. (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale. J. Biol. Med. 42:311–28. Halstead, S.B., Scanlon, J., Umpaivit, P. and Udomsakdi, S. (1969) Dengue and chick ungunya virus infection in man in Thailand, 1962–1964. IV. Epidemiologic studies in the Bangkok metropolitan area. Am. J. Trop. Med. Hyg. 18:997–1021. Halstead, S. B. (1970) Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale Journal of Bilology and Medicine 42:350-362. Halstead, S. B. (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481. Halstead, S. B. (1989) Antibody, macrophage, dengue virus infection, shock and hemorrhage: A pathogenetic cascade. Rev. Infect. Dis. 11:S830-839. Halstead, S. B., Venkateshan, C. N., Gentry, M. K. & Larsen, L. K. (1984). Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 132:1529–1532. Hammon, W.M. (1973) Dengue hemorrhagic fever – do we know its cause? American Journal of Tropical Medicine and Hygiene 22:82-91. Heinz, F. X. and Roehrig, J. T. (1990) Flaviviruses. In: Van Regenmortel, M.H.V and Neurath, A. R. (eds) Immunochemistry of Viruses Ⅱ. The Basis for Serodiagnosis and Vaccines. Elsevier, Amsterdam, pp.289-305. Heinz, F. X., Berger, R., Tuma, W. and Kunz, C. A. (1983) Topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126:525-537. Heiskanen, T., Lundkvist, A., Vaheri, A. and Lankinen, H. (1997) Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J. Virol.71:3879–3885. Henchal, E. A., Henchal, L. S. and Thaisomboonsuk, B. K. (1987) Topological mapping of unique epitopes on the dengue-2 virus NS1 protein using monoclonal antibodies. J. Gen. Virol. 68 (pt 3):845-51. Hidayah, N., Darmowandowo, W., Ismoedijanto. and Soegijanto, S. (2000) Dengue hemorrhagic fever in infant (clinical aspects, immunological responses related to the clinical degrees) [abstract]. In: Program and abstracts of the 1st International Conference on Dengue/Dengue Hemorrhagic Fever (Chiang Mai, Thailand). Geneva: World Health Organization: 11. Hiramatsu, K., Tadano, M., Men, R. and Lai, C. J. (1996) Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology 224:437-445 Holzmann, H., Stiasny, K., Ecker, M., Kunz, C. and Heinz, F. X. (1997) Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J. Gen. Virol. 78:31-37. Hwang, K. P. (1997) Dengue fever and dengue hemorrhagic fever. J. Formosan. Med. 1: 48-55. Innis, B. L., Thirawuth, V. and Hemachudha, C. (1989) Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. Am. J. Trop. Med. Hyg. 40: 676-687. Innis, B. L., V. Thirawuth, and C. Hemachudha. (1989) Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. Am. J. Trop. Med. Hyg. 40:676–687. Irie, K., Mohan, P. M., Sasaguri, Y., Putnak, R., and Padmanabhan, R. (1989) Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene 75(2):197-211. Jindadamrongwech, S., Thepparit, C. and Smith, D. R. (2004) Identification of GRP78 (Bip) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 149:915-927 Johnson, B. W., Chambers, T.V., Crabtree, M.B., Arroyo, J., Monath, T.P. and Miller, B.R. (2003) Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med. Vet. Entomol. 17:235–43. Johnson, B.W., Chambers, T.V., Crabtree, M.B., Guirakhoo, F., Monath, T.P. and Miller, B.R. (2004) Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. Am. J. Trop. Med. Hyg. 70:89–97. Johnson, A. J., Guirakoo, F. and Roehrig, J. T. (1994) The envelope glycoprotein of dengue 1 and dengue 2 virus grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203:241-249. Kanesa-Thasan, N., Sun, W., Kim-Ahn, G. et al. (2001) Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 19:3179–3188. Kliks, S.C., Nimmannitya, S., Nisalak, A. and Burke, D.S. (1988) Evidence that maternal antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:411–419. Kliks, S.C., Nisalak, A., Brandt, W.E., Wahl, L. and Burke, D.S.(1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444–451. Kohler, G. and Milstein G. (1975) Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256:495–497. Koivunen, E., Arap, W., Rajotte, D., Lahdenranta, J. and Pasqualini, R. (1999) Identification of receptor ligands with phage display peptide libraries. J. Nucl. Med. 40:883–888. Konishi, E. and Mason, P. W. (1993) Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67(3):1672-1675. Kraft, S., Diefenbach, B., Mehta, R., Jonczyk, A., Luckenbach, G. A. and Goodman, S. L. (1999) Definition of an unexpected ligand recognition motif for avb6 integrin. J. Biol. Chem. 274:1979–1985. Kurane, I., Brinton, M. A., Samson, A. L. and Ennis, F. A. (1991) Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65(4):1823-1828. Kurane, I. and Ennis, F. A. (1997) Immunopathogenesis of dengue virus infections. In: Gubler DJ, Kuno G, eds. Dengue and dengue haemorrhagic fever. Wallingford, Oxon, U.K: CAB International:273–290. Kurane, I., Rothman, A. L., Livingston, P. G., Green, S., Gagnon, S. J., Janus, J., Innis, B. L., Nimmannitya, S., Nisalak, A. and Ennis, F. A. (1994) Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Archives of Virology 9:59-63. Lam, S. K. and Devine, P. L. (1998) Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection. Clin. Diagn. Virol. 10:75–81. Lan, N.T., Hung, N.T. and Lien, L.B. (1997) Dengue hemorrhagic fever in infants. In: Program and abstracts of the 4th International Symposium on Dengue Fever (Tahiti, French Polynesia). Geneva: World Health Organization: 43. Laver, W. G., Air, G. M., Webster, R. G. and Smith-Gill, S. J. (1990) Epitopes on protein antigens: misconceptions and realities. Cell 61:553–556. Lee, T. Y., Wu, H. C. Tseng, Y. L. and Lin C. T. (2004) A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery. Cancer Research 64:8002-8008. Lei, H.Y., Yeh, T.M., Liu, H.S., Lin, Y.S., Chen, S.H. and Liu, C.C. (2001) Immunopathogenesis of dengue virus infection. J. Biomed. Sci. 8:377–88. Li, B., Tom, J. Y., Oare, D., Yen, R., Fairbrother, W. J., Wells, J. A. and Cunningham, B. C. (1995) Minimization of a polypeptide hormone. Science 270:1657–1660. Lin, B., Parrish, C. R., Murray, J. M. and Wright, P. J. (1994) Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202:885-890. Liu, I. J., Hsueh, P. R., Lin, C. T., Chiu, C. Y., Kao, C. L., Liao, M. Y. and Wu, H. C. (2004) Disease-specific B cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens. J. Infect. Dis. 190:797-809. Lorenz, I. C., Allison, S. L., Heinz, F. X. and Helenius, A. (2002) Folding and dimerization of tick-borne encephalitis virus envelop proteins prM and E in the endoplasmic reticulum. J. Virol. 76(11):5480-5491. Malasit, P. (1987) Complement and dengue hemorrhagic fever/shock syndrome. Southeast Asian Journal of Tropical Medicine and Public Health 18:316-320. Mandl, C. W., Allison, S. L., Holzmann, H., Meixner, T. and Heinz, F. X. (2000) Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J. Virol. 74(20):9601-9609. Mandl, C.W., Guirakhoo, F.G Holzman, H., Heinz, F.X. and Kunz, C. (1989) Antigenic structure of the flavivirus envelope protein Eat the molecular level, using tick-borne encephalitis virus a model. Jorunal of Virology 63:564-571. Mason, P. W., Zugel, M. U., Semproni, A. R., Fournier, M. J. and Mason, T. L. (1990)The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J. Gen. Virol. 71:2107–2114. Mazzucchelli, L., Burritt, J. B., Jesaitis, A. J., Nusrat, A., Liang, T. W., Gewirtz, A. T., Schnell, F. J. and Parkos, C. A. (1999) Cell-specific peptide binding by human neutrophils. Blood 93:1738–1748. Megret, F., J. P. Hugnot, A. Falconar, M. K. Gentry, D. M. Morens, J. M. Murray, J. J. Schlesinger, P. J. Wright, P. Young, M. H. Van Regenmortel, and V. Deubel. (1992) Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187:480–491. Monath, T.P., McCarthy, K., Bedford, P. et al. (2002) Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine 20:1004–1018. Morens, D.M., Halstead, S.B., Repik, P. M., Putvatana, R. and Raybourne, N. (1985) Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22:250–254. Navarro-Sanchez, E. et al. (2003) Dendritic-cell –specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic dells by mosquito-cell-derived dengue viruses. EMBO Rep. 4:723-728. Nord, K., Gunneriusson, E., Ringdahl, J., Stahl, S., Uhlen, M. and Nygren, P. A. (1997) Binding proteins selected from combinatorial libraries of an a-helical bacterial receptor domain. Nat. Biotechnol. 15:772–777. Nowak, T., and Wengler, G. (1987) Analysis of disulfides present in the membrane proteins allow West Nile flavivirus. Virology 156(1):127-137. Pancharoen, C. and Thisyakorn, U. (2001) Dengue virus infection during infancy. Trans. R. Soc. Trop. Med. Hyg. 95:307–308. Pasqualini, R. and Ruoslahti, E. (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364–366. Pasqualini, R., Koivunen, E. and Ruoslahti, E. (1995) A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J. Cell. Biol. 130:1189–1196. Prezzi, C., Nuzzo, M., Meola, A., Delmastro, P., Galfre, G., Cortese, R., Nicosia, A. and Monaci, P. (1996) Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156:4504–4513. Pugachev, K.V., Guirakhoo, F., Trent, D.W. and Monath, T.P. (2003) Traditional and novel approaches to flavivirus vaccines. Int. J. Parasitol. 33:567–582. Putnak. R., Barvir, D.A., Burrous, J.M. et al. (1996) Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys. J. Infect. Dis. 174:1176–1184. Rajotte, D. and Ruoslahti, E. (1999) Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J. Biol. Chem. 274:11593–11598. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. and Harrison, S.C. (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375(6529):291-298. Roehrig, J. T., Bolin, R. A. and Kelly, R. G. (1998) Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317-328. Roehrig, J. T., Johnson, A. J., Hunt, A. R., Bolin, R. A. and Chu, M. C. (1990) Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 177:668-675. Rothman, A. L. and Ennis, F. A. (1999) Immunopathogenesis of dengue hemorrhagic fever. Virology 257:1–6. Ruangjirachuporn, W., Boonpucknavig, S. and Nimmanitya, S. (1979) Circulating immune complexes in serum from patients with dengue haemorrhagic fever. Clinical and Experimental Immunology 36:46-53. Sabchareon, A., Lang, J., Chanthavanich, P. et al. (2002) Safety and immunogenicity of tetravalent liveattenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses. Am. J. Trop. Med. Hyg. 66:264–272. Sabchareon, A., Lang, J., Chanthavanich, P. et al. (2004) Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Ped. Infect. Dis. J. 23:99–109. Sabin A. (1952) Research on dengue in World War II. Amer. J. Trop. Med. 1:30–50. Sangkawibha, N., Rojanasuphot, S., Ahandrik, S., Viriyapongse, S., Jatanasen, S., Salitual, V., Phanthumachinda, B. and Halstead, S. B.(1984) Risk factors for dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. American Journal of Epidemiology 120:653-669. Scott, J. K. and Smith, G. P. (1990) Searching for peptide ligands with an epitope library. Science 249:386–390. Sela, M. (1969) Antigenicity: some molecular aspects. Science 166:1365–1374. Simantini, E. and Banerjee, K. (1995) Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies. Arch. Virol. 140:1257-1273. Smith, W. C., McDowell, J. H., Dugger, D. R., Miller, R., Arendt, A., Popp, M. P. and Hargrave, P. A. (1999). Identification of regions of arrestin that bind to rhodopsin. Biochemistry 38:2752–2761. Sobel, A. T., Bokisch, C. A. and Muller-Eberhard, H. J. (1975) C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum. Journal of Experimental Medicine 142:139-150. Sullivan, N.J. (2001) Antibody-mediated enhancement of viral disease. Curr. Top. Microbiol. Immunol. 260:145–69. Sun, W., Edelman, R., Kanesa-Thasan, N. et al. (2003) Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. Am. J. Trop. Med. Hyg. 69:24–31. Szardenings, M., Tornroth, S., Mutulis, F., Muceniece, R., Keinanen, K., Kuusinen, A. and Wikberg, J. E. (1997) Phage display selection on whole cells yields a peptide specific for melanocortin receptor 1. J. Biol. Chem. 272:27943–27948. Tassaneetrithep, B. et al. (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197:823-829. Theofilopoulos, A. N., Wilson, C. B. and Dixon, F. J. (1976) The Raji cell radioimmune assay for detecting immune complexes in human sera. Journal of Clinical Investigation 57:169-182. Trirawatanapong, T., Chandran, B., Putnak, R. and Padmanabhan, R. (1992) Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody. Gene 116:139-150. Tsekhanovskaya, N. A., Matveev, L. E., Rubin, S. G., Karavanov, A. S. and Pressman, E. K. (1993) Epitope analysis of tick-borne encephalitis (TBE) complex viruses using monoclonal antibodies to envelope glycoprotein of TBE virus (persulcatus subtype). Virus Res. 30:1-16. Tsishe, H. C. (1932) Dengue epidemic in Tainan area in Cho-Ho 6th year. Formosa J. Med. 31:767-71. Tyler, K.L. and Fields, B.N. (1996) Pathogenesis of viral infections. In: Fields, B.N., Knipe, D.M. and Howley, P.M. (eds) Virology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, pp:173-218. Vaughn, D. W. S. Green, S. Kalayanararooj, et al. (1997) Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176:322 Vaughn, D. W., Nisalak, A., Kalayanarooj, S., Solomon, T., Dung, N. M., Cuzzubbo, A. and Devine, P. L. (1998) Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J. Clin. Microbiol. 36:234–238. Vaughn, D. W., Nisalak, A., Solomon, T., Kalayanarooj, S., Nguyen, M. D., Kneen, R., Cuzzubbo, A. and Devine, P. L. (1999) Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am. J. Trop. Med. Hyg. 60:693–698. Vorndam, V., Mathews, J. H., Barrett, A. D. T., Roehrig, J. T. and Trent, D. W. (1993) Molecular and biological characterization of a non-glycosylated isolate of St. Louis encephalitis virus. Journal of General Virology 74:2653-2660. Westaway, E. G. and Blok, J. (1997) Taxonomy and evolutionary relationships of flaviviruses. In Dengue and Dengue Hemorrhagic Fever, pp. 147–173. Edited by D. J. Gubler & G. Kuno. New York:CAB International. White, D. J. (1999) Variation in virulence of dengue virus. The Lancet 354:1401-1402. Winkler, G., Heinz, F. X. and Kunz, C. (1987) Studies on the glycosyoation of flavivirus E proteins and the role of carbohydrate in antigenic structure. Virology 159:237-243. Witayathawornwong, P. (2001) Dengue hemorrhagic fever in infancy at Petchabun Hospital, Thailand. Southeast Asian J Trop Med Public Health 32:481–487. World Health Organization (WHO) (1997). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition. Geneva: WHO World Health Organization (WHO) (2002) Dengue and dengue haemorrhagic fever. Fact sheet N.117. Geneva: WHO. Wrighton, N. C., Farrell, F. X., Chang, R. and 7 other authors (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458–463. Wu, H. C., Huang, Y. L., Chao, T. T., Jan, J. T., Huang, J. L., Chiang, H. Y., King, C. C. and Shaio, M. F. (2001a) Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients. J. Clin. Microbiol. 39:977–982. Wu, H. C., Jung, M. Y., Chiu, C. Y., Chao, T. T., Lai, S. C., Jan, J. T. and Shaio, M. F. (2003) Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen. J. Gen. Virol. 84:2771-2779. Wu, H. C., Yeh, C. T., Huang, Y. L., Tarn, L. J. and Lung, C. C. (2001b) Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A. Appl. Environ. Microbiol. 67:3201–3207. Wu, Y. C. (1986) Epidemic dengue 2 on Liouchyou Shiang, Pingtung County in 1981. Chinese J. Microbiol. Immunol. 19: 203-211. Yorgo, M., Steven, O., David, C. and Stephen, C. H. (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427(22):313-319. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35634 | - |
| dc.description.abstract | 登革病毒引發人類嚴重疾病，包括有登革出血熱和登革休克症候群。近來，本研究室過去己確認第一型和第二型登革病毒的血清專一型B細胞抗原決定位。本研究因此利用登革第二型和第四型的登革病毒對BABL/c老鼠進行免疫，並以融合瘤技術生產對抗第二型和第四型登革病毒的單株抗體。初步結果己生產對抗第二型和第四型登革病毒的單株抗體分別有九株和十一株。這些單株抗體在酵素連結免疫吸附分析法、免疫螢光染色法以及免疫墨點法測試中對登革病毒有專一性的反應。一些單株抗體對抗病毒的套膜蛋白(E proteins)，另一些對抗病毒的非結構性蛋白(Non-structural protein 1)和前驅膜蛋白(prM proteins)。有四株單株抗體(DB23-30-7, DB24-2-6, DB13-19-1, DD11-42-12)在溶斑減少試驗法(PRNT)的測試中被證實對登革病毒的感染途徑發揮中和性效用。我們也利用Phage display的技術確認這些單株抗體其血清專一性和中和性B細胞抗原決定位。這些單株抗體以及藉由抗原決定位胜肽抗原可以幫助我們做登革病毒感染的血清學診斷和研發登革疫苗的依據。此外，相信藉由中和性抗體所確認的這些抗原決定位可以幫助我們了解登革病毒感染時，抗體所扮演的角色，以及這些抗體於初次或二次感染登革病毒的登革出血熱時在致病機轉上所扮演的角色。 | zh_TW |
| dc.description.abstract | Dengue virus (DEN) causes serious febrile illness in humans, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Recently, we identified the serotype-specific B-cell epitopes of DEN-1 (Wu et al., 2001) and DEN-2 (Wu et al., 2003). In this study, we generated monoclonal antibodies (MAbs) against DEN-2 and DEN-4 by fusing NS1/1-Ab4-1 (NS-1) mouse myeloma cells with lymphocytes from BALB/c mice immunized with DENs. We have generated nine and eleven MAbs against DEN-2 and DEN-4, respectively. The specificity of MAbs was identified by ELISA, immunofluorescence, and immunoblotting analysis. Several MAbs revealed to recognize envelope proteins (E proteins), non-structural protein 1 (NS1) and prM proteins. Four MAbs (DB23-30-7, DB24-2-6, DB13-19-1 and DD11-42-12) further demonstrated to neutralize DEN infection by plaque reduction neutralization test (PRNT) assay. The serotype-specific and neutralizing B-cell epitopes of MAbs were also identified by phage-displayed random peptide library. These MAbs and their epitope-based peptide antigens will be valuable for serologic diagnosis of DEN infection. The neutralizing MAbs and B-cell epitopes will be valuable for development of DEN vaccine. Furthermore, identification of these epitopes makes it feasible to dissect the antibody response and to address the role of antibodies in the pathogenesis of primary and secondary DEN infections. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:02:13Z (GMT). No. of bitstreams: 1 ntu-94-R92450006-1.pdf: 687749 bytes, checksum: b40e315dbb5539814dbb4b798fb5bdc0 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | CONTENTS
中文摘要………………………………………………………….2 ABSTRACT………………………………………………………3 ABBREVIATION………………………………………………...4 INTRODUCTION………………………………………………..6 MATERIALS & METHODS……………………………………20 RESULTS…………………………………………………………30 DISCUSSION……………………………………………………..39 FIGURES………………………………………………………….47 TABLE…………………………………………………………….69 REFFERNCES……………………………………………………75 | |
| dc.language.iso | en | |
| dc.subject | 登革病毒 | zh_TW |
| dc.subject | dengue virus | en |
| dc.title | 第二型及第四型登革病毒單株抗體之製備和功能探討 | zh_TW |
| dc.title | Generation and Characterization of Monoclonal Antibodies Against Dengue Virus Type Ⅱ and Ⅳ | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 林欽塘(Chin-Tarng Lin),金傳春(Chwan-Chuen King),高全良(Chuan-Liang Kao) | |
| dc.subject.keyword | 登革病毒, | zh_TW |
| dc.subject.keyword | dengue virus, | en |
| dc.relation.page | 88 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-27 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
| 顯示於系所單位： | 口腔生物科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 671.63 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。